title: Why we don't need a relative risk standard for adolescent HIV vaccine trials in South Africa.
authors.affiliation: University of KwaZulu-Natal, Scottsville, Pietermaritzburg 3201, South Africa. slackca@ukzn.ac.za
authors.forename: Catherine M
authors.initials: CM
authors.lastname: Slack
mesh_terms: D016915:AIDS Vaccines / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D000293:Adolescent; D002986:Clinical Trials as Topic / Q000941:ethics* / Q000379:methods; D055812:Community-Based Participatory Research / Q000941:ethics* / Q000379:methods; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D033281:Nontherapeutic Human Experimentation / Q000941:ethics; D018579:Patient Selection / Q000941:ethics*; D011322:Primary Prevention / Q000941:ethics* / Q000379:methods; D012306:Risk; D012309:Risk-Taking; D013019:South Africa
chemical_list: D016915:AIDS Vaccines